MGI Revolutionizes Agrigenomics Research and Molecular Breeding with Advanced Sequencing Technology and Platforms. Discover the Future of Agriculture with MGI's Innovations.

Unveiling MGI's Customer Experience Center in Berlin: Empowering Precision Medicine. Explore MGI's new Customer Experience Center in Berlin, Germany, fostering precision medicine through innovative automation and sequencing. Revolutionize cancer diagnostics, personalized oncology services, and cutting-edge technologies.

Celebrating the MGISP-Smart 8's European launch and our Empowerment Program at MEDICA, MGI continues to pioneer genomics research through steadfast innovation.

MGI Tech Co., Ltd. launches an overseas production line in Latvia to assemble the advanced DNBSEQ-G400* gene sequencing instruments and Sequencing reagents, marking a significant milestone in MGI's expansion into the European market.

Explore MGI Tech Co. Ltd.'s significant contributions to the Million Microbiome of Humans Project (MMHP), a collaborative effort aiming to construct a comprehensive microbiome map of the human body. This post highlights MGI's innovative sequencing technology, the importance of microbiome in human health, and the future of microbiomics in precision medicine. Discover how MGI is reshaping the future of microbiome research and healthcare.

Discover the strategic collaboration between MGI Tech Co. Ltd., a global leader in life science technology, and AddLife AB, a major European distributor of clinical testing and laboratory equipment. Learn how this partnership aims to revolutionize life science in the Nordic region through the distribution of MGI's innovative products and expansion into fields like point-of-care testing and remote ultrasound.

Discover the groundbreaking partnerships and innovations unveiled by MGI Tech Co., Ltd. at the ESHG Conference in Glasgow. Learn about MGI's strategic collaborations in the European life sciences market, their advancements in sequencing and automation technologies, and their commitment to revolutionizing genomics research. This post also highlights MGI's strategic partnership with Alithea Genomics, aiming to innovate in RNA sequencing.

Explore MGI's latest achievement as its DNBSEQ-T20×2 gene sequencing platform wins the prestigious Globee® for Medical Equipment in the 15th Annual 2023 Golden Bridge Business and Innovation Awards®. This post highlights MGI's commitment to innovation in the life science industry, their groundbreaking T20 gene sequencer, and how their technology is reshaping healthcare outcomes and the genetic industry.

Latvia MGI Tech SIA advances DNA methylation research with significant European funding, achieving groundbreaking progress in biotechnology and innovation.

MGI Tech has joined forces with Eurofins Genomics Europe Genotyping A/S, marking a pivotal moment in the advancement of large-scale genomic projects. This partnership heralds the first corporate order of the DNBSEQ-T20×2 ("T20") ultra-high throughput sequencer in Europe.